Signos Introduces First FDA-Cleared Glucose Monitoring System for Weight Management

Signos has launched the first over-the-counter, FDA-cleared glucose monitoring system designed to help individuals manage their weight and metabolic health. 

The Signos Glucose Monitoring System combines a wearable glucose biosensor with an AI-powered platform that interprets each user’s unique metabolism, providing real-time, personalised insights.

The system enables users to see how their bodies respond to meals, exercise, sleep, and stress. By transforming glucose data into clear, actionable guidance, it supports healthier daily habits, improved sleep, and weight management – all without the need for prescriptions or expensive clinical procedures.

With metabolic health concerns on the rise, including obesity and diabetes, Signos aims to put control back into the hands of individuals. In the U.S., nearly three-quarters of adults are overweight or obese, while more than 85% are considered metabolically unhealthy. 

Signos offers a proactive approach, helping users make informed lifestyle choices before serious health issues develop.

The Signos Glucose Monitoring System is now available and can be accessed through a smartphone. 

By providing personalised, easy-to-understand insights, it empowers users to monitor their metabolism, make better choices, and take charge of their long-term health.